A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy

A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy
复制标题

DOI:
10.1097/01.gme.0000185753.77704.65
复制
发表时间:
2006-05-01
影响因子:
2.7
通讯作者:
Schulkin, J
Schulkin, J
中科院分区:
医学3区
文献类型:
--
作者:
Power, ML;Zinberg, S;Schulkin, J

文献摘要

被引文献

相似文献

目的:要检查的知识和处方的做法,妇产科医生关于激素治疗的妇女健康倡议研究结合雌激素+existestin.Design发表的证据:一份调查问卷被发送到2,500名随机选择的研究员的美国大学妇产科医师在2003年11月,705调查返回。其中,644报告他们的专业产科和/或妇科和这些反应reported.Results:大多数的医生,完成了他们的居住在1995年之前,男性和女性,不相信WHI的研究结果,并不同意决定结束试验。那些认为自己对解释科学文献的能力非常有信心的医生更有可能对结果不信服,并不同意结束试验的决定。一般来说,最近完成住院医师资格的医生认为激素治疗的益处较低,风险较高。大多数受访者(53.3%)报告说,他们的处方做法不太可能改变;然而,29.6%的人报告说,他们将有点不太可能和9.5%显着不太可能处方激素治疗。医生报告说,他们的病人不太可能要求激素治疗(91.8%),更有可能停止使用(93.0%)。结论:医生谁在实践中更长的时间是更积极的风险和利益的HT,并对最近的研究持怀疑态度。已发表的数据似乎影响了患者的偏好,并对医生的处方实践产生了一定的影响。
Objective: To examine the knowledge and prescribing practices of obstetrician-gynecologists regarding hormone therapy in light of the published evidence from the Women's Health Initiative study on combined estrogen+progestin.Design: A survey questionnaire was sent to 2,500 randomly selected Fellows of the American College of Obstetricians and Gynecologists in November of 2003; 705 surveys were returned. Of those, 644 reported their specialty as obstetrics and/or gynecology and those responses are reported.Results: A majority of physicians that completed their residency before 1995, both men and women, were not convinced by the WHI research results and disagreed with the decision to end the trial. Physicians that rated themselves very confident about their ability to interpret the scientific literature were more likely to be unconvinced by the results and to disagree with the decision to end the trial. In general, physicians who completed their residency more recently rated the benefits of hormone therapy lower and the risks higher. A majority of respondents (53.3%) reported that their prescribing practices were unlikely to change; however, 29.6% reported that they would be somewhat less likely and 9.5% dramatically less likely to prescribe hormone therapy. Physicians reported that their patients were less likely to request hormone therapy (91.8%) and were more likely to discontinue use (93.0%).Conclusion: Physicians who have been in practice longer were more positive about the risks and benefits of HT, and were more skeptical about the recent research. The published data seem to have affected patient preferences and to have had some effect on physician prescribing practices.